Oct 20 - Nov 2, 2025
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Oct 20 - Nov 2, 2025
-
Narrated by:
-
Written by:
About this listen
🔬 This Week’s Top Biotech News
Here are the biggest stories shaping the world of biotechnology this week 👇
- Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
- Biopharma Embraces Synthetic Biology
- Sanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPD
- StockWatch: Intellia Shares Sink as Clinical Hold Follows Safety Setback
- Bird Flu’s Human Risk Spurs Phage Therapy Research
- This Retina Implant Lets People with Vision Loss Do a Crossword Puzzle
- Neurenati Therapeutics – EMA Grants Orphan Drug Designation to NEU-001 for Hirschsprung Disease
- The Astonishing Embryo Models of Jacob Hanna
- The Latest Company Planning for Gene-Edited Babies
- Mass Spec Brings Multiomics Into Sharper Focus
- Why We Don’t Have a Cold Vaccine — Yet
- Job Titles of the Future: AI Embryologist
🧬 From Alzheimer’s breakthroughs to gene editing ethics and synthetic biology advances, biotech continues to evolve at lightning speed.
What story caught your attention this week?
#Biotech #Biotechnology #Science #Innovation #Healthcare #Research #LifeSciences
No reviews yet